Found: 10
Select item for more details and to access through your institution.
Neurohormonal Regulation of I<sub>Ks</sub> in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Letrozole targets the human ether‐a‐go‐go–related gene potassium current in glioblastoma.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 357, doi. 10.1111/bcpt.13515
- By:
- Publication type:
- Article
Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 6, p. 693, doi. 10.1007/s10557-019-06909-6
- By:
- Publication type:
- Article
Computational pharmacogenotype extraction from clinical next-generation sequencing.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1199741
- By:
- Publication type:
- Article
Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant Program.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 8, p. 961, doi. 10.1002/jcph.2249
- By:
- Publication type:
- Article
Progesterone Metabolites Inhibit the Human Ether-a-go-go-Related Gene and Predict QT Interval Length.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 5, p. 648, doi. 10.1002/jcph.1563
- By:
- Publication type:
- Article
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
- Published in:
- NPJ Genomic Medicine, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41525-020-00156-7
- By:
- Publication type:
- Article
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2016, v. 27, n. 10, p. 1206, doi. 10.1111/jce.13032
- By:
- Publication type:
- Article
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid‐Reducing Agents.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 5, p. 1088, doi. 10.1002/cpt.2723
- By:
- Publication type:
- Article